Strategic Advisors LLC Pfizer Inc Transaction History

Strategic Advisors LLC

$530 Million
Q3 2024

A detailed history of Strategic Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Strategic Advisors LLC holds 131,266 shares of PFE stock, worth $3.53 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

131,266

Previous 126,793 3.53%

Holding current value

$3.53 Million

Previous $3.55 Million 7.08%

% of portfolio

0.72%

Previous 0.7%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	BUY	$27.7 - $31.39 $123,902 - $140,407	4,473 Added 3.53%	131,266 $3.8 Million
Q2 2024 Jul 11, 2024	BUY	$25.26 - $29.6 $44,634 - $52,303	1,767 Added 1.41%	126,793 $3.55 Million
Q1 2024 Apr 19, 2024	BUY	$25.89 - $29.73 $331,625 - $380,811	12,809 Added 11.41%	125,026 $3.47 Million
Q4 2023 Jan 19, 2024	SELL	$26.13 - $33.94 $623,174 - $809,435	-23,849 Reduced 17.53%	112,217 $3.23 Million
Q3 2023 Oct 13, 2023	SELL	$32.09 - $37.51 $237,562 - $277,686	-7,403 Reduced 5.16%	136,066 $4.51 Million
Q2 2023 Jul 31, 2023	SELL	$36.12 - $41.79 $261,075 - $302,058	-7,228 Reduced 4.8%	143,469 $5.26 Million
Q1 2023 Apr 27, 2023	BUY	$39.39 - $51.28 $181,469 - $236,246	4,607 Added 3.15%	150,697 $6.15 Million
Q4 2022 Jan 23, 2023	SELL	$41.75 - $54.5 $166,415 - $217,237	-3,986 Reduced 2.66%	146,090 $0
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $107,387 - $131,092	-2,454 Reduced 1.61%	150,076 $6.57 Million
Q2 2022 Aug 03, 2022	SELL	$46.53 - $55.17 $204,452 - $242,416	-4,394 Reduced 2.8%	152,530 $8 Million
Q1 2022 May 10, 2022	BUY	$45.75 - $56.69 $2.74 Million - $3.39 Million	59,812 Added 61.59%	156,924 $8.12 Million
Q4 2021 Jan 21, 2022	BUY	$41.32 - $61.25 $1.9 Million - $2.82 Million	46,029 Added 90.11%	97,112 $5.73 Million
Q3 2021 Oct 21, 2021	SELL	$39.25 - $50.42 $38,386 - $49,310	-978 Reduced 1.88%	51,083 $2.2 Million
Q2 2021 Aug 10, 2021	BUY	$35.91 - $40.68 $1.38 Million - $1.56 Million	38,296 Added 278.21%	52,061 $2.04 Million
Q1 2021 May 05, 2021	SELL	$33.49 - $37.77 $1.14 Million - $1.28 Million	-33,913 Reduced 71.13%	13,765 $498,000
Q4 2020 Feb 11, 2021	SELL	$33.47 - $42.56 $917,278 - $1.17 Million	-27,406 Reduced 36.5%	47,678 $1.77 Million
Q3 2020 Oct 13, 2020	SELL	$31.75 - $37.25 $84,201 - $98,787	-2,652 Reduced 3.41%	75,084 $2.76 Million
Q2 2020 Aug 12, 2020	BUY	$30.12 - $36.54 $349,211 - $423,644	11,594 Added 17.53%	77,736 $3 Million
Q1 2020 Apr 30, 2020	SELL	$27.03 - $38.62 $129,662 - $185,260	-4,797 Reduced 6.76%	66,142 $2.29 Million
Q4 2019 Feb 05, 2020	SELL	$32.92 - $37.36 $33,315 - $37,808	-1,012 Reduced 1.41%	70,939 $2.78 Million
Q3 2019 Oct 17, 2019	SELL	$32.49 - $42.13 $78,073 - $101,238	-2,403 Reduced 3.23%	71,951 $2.59 Million
Q2 2019 Jul 22, 2019	SELL	$36.98 - $41.52 $8,949 - $10,047	-242 Reduced 0.32%	74,354 $3.22 Million
Q1 2019 Apr 15, 2019	SELL	$37.5 - $41.2 $75,787 - $83,265	-2,021 Reduced 2.64%	74,596 $3.17 Million
Q4 2018 Jan 24, 2019	SELL	$38.47 - $43.86 $69,899 - $79,693	-1,817 Reduced 2.32%	76,617 $3.34 Million
Q3 2018 Oct 18, 2018	SELL	$34.47 - $41.81 $3,274 - $3,971	-95 Reduced 0.12%	78,434 $3.46 Million
Q2 2018 Jul 30, 2018	BUY	$32.98 - $35.16 $3,429 - $3,656	104 Added 0.13%	78,529 $2.85 Million
Q1 2018 Apr 19, 2018	SELL	$31.91 - $37.02 $35,707 - $41,425	-1,119 Reduced 1.41%	78,425 $2.78 Million
Q4 2017 Jan 16, 2018	SELL	$33.26 - $35.29 $40,477 - $42,947	-1,217 Reduced 1.51%	79,544 $2.88 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $33,511 - $36,916	1,081 Added 1.36%	80,761 $2.88 Million
Q2 2017 Aug 10, 2017	BUY	N/A	79,680	79,680 $2.68 Million

Others Institutions Holding PFE

# of Institutions

3,257

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $151B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Advisors LLC with notifications on news.

Account

Strategic Advisors LLC Pfizer Inc Transaction History